What is new in the European Society of Cardiology 2014 update on myocardial revascularization guidelines?

References (9)

1. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascula- rization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Develo- ped with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619
2. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55
3. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bu- eno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting wit- hout persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054
4. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lund- qvist C, Borger MA, et al. ESC Guidelines for the manage- ment of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619
5. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the ma- nagement of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003
6. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012;41:734-45
7. Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergo- uwe Y, Chieffo A, et al. Anatomical and clinical characteris- tics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013;381:639-50
8. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367:2375-84
9. Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW, et al. Greater clinical benefit of more inten- sive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in thera- peutic outcomes by optimizing platelet inhibition with pra- sugrel-Thrombolysis in Myocardial Infarct